Cognitive impairment associated with schizophrenia: a review of the humanistic burden
- PMID: 22351433
- DOI: 10.1007/s12325-012-0001-4
Cognitive impairment associated with schizophrenia: a review of the humanistic burden
Abstract
Introduction: Nearly every individual with schizophrenia is affected by cognitive decline. The aim of this literature review was to: (a) describe the humanistic burden of cognitive impairment associated with schizophrenia (CIAS); (b) develop a conceptual model that depicts the signs and symptoms of CIAS along with key concepts important to patients; and (c) consider the adequacy of potential patient-reported outcome (PRO) instruments for assessing future treatments.
Methods: The following electronic databases were searched for articles published between January 1999 and November 2009 related to CIAS and PROs, or cost of illness: Medline; Embase; PsycINFO; the Health Economic Evaluation Database; and the National Health Service Economic Evaluation Database and Health Technology Assessment databases at the Centre for Reviews and Dissemination, University of York.
Results: The literature search revealed 3950 abstracts, of which 101 articles were reviewed in detail. Cognitive functions affected include memory, attention/concentration, problem solving, learning, executive function, processing speed, and social cognition. Cognitive impairment impacts the ability of individuals to carry out activities of daily living, work productively, function socially, and adhere to treatment. These effects have economic ramifications through increased direct and indirect costs associated with the treatment of schizophrenia. The literature revealed 39 PRO instruments that have been used to assess functioning. However, no single instrument captures all key concepts of importance to patients with schizophrenia.
Conclusion: The significant burden from CIAS for patients and society has implications for designing future treatments and health strategies to improve functional outcomes.
Similar articles
-
Humanistic burden in schizophrenia: a literature review.J Psychiatr Res. 2014 Jul;54:85-93. doi: 10.1016/j.jpsychires.2014.03.021. Epub 2014 Apr 4. J Psychiatr Res. 2014. PMID: 24795289 Review.
-
[Cognitive remediation and cognitive assistive technologies in schizophrenia].Encephale. 2009 Apr;35(2):160-7. doi: 10.1016/j.encep.2008.02.010. Epub 2008 Jun 2. Encephale. 2009. PMID: 19393385 French.
-
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French.
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
[Learning potential and cognitive remediation in schizophrenia].Encephale. 2009 Sep;35(4):353-60. doi: 10.1016/j.encep.2008.06.014. Epub 2009 Jan 8. Encephale. 2009. PMID: 19748372 Review. French.
Cited by
-
Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study.Clin Drug Investig. 2020 Apr;40(4):355-375. doi: 10.1007/s40261-020-00900-y. Clin Drug Investig. 2020. PMID: 32152867 Free PMC article.
-
Investigation of the Relationship Between Cognitive Functions and Retinal Findings From Spectral Optical Coherence Tomography in Patients With Schizophrenia and Their Healthy Siblings.Psychiatry Investig. 2023 Mar;20(3):236-244. doi: 10.30773/pi.2022.0268. Epub 2023 Mar 22. Psychiatry Investig. 2023. PMID: 36990667 Free PMC article.
-
Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment.Clin Drug Investig. 2024 Jul;44(7):471-493. doi: 10.1007/s40261-024-01377-9. Epub 2024 Jun 21. Clin Drug Investig. 2024. PMID: 38904739 Review.
-
Habituation during encoding: A new approach to the evaluation of memory deficits in schizophrenia.Schizophr Res. 2020 Sep;223:179-185. doi: 10.1016/j.schres.2020.07.007. Epub 2020 Jul 28. Schizophr Res. 2020. PMID: 32736836 Free PMC article.
-
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment.Mol Psychiatry. 2023 May;28(5):1902-1918. doi: 10.1038/s41380-023-01949-9. Epub 2023 Jan 23. Mol Psychiatry. 2023. PMID: 36690793 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous